Immunocore Holdings plc (IMCR) reported Q4 EPS of ($0.63), $0.65 worse than the analyst estimate of $0.02. Revenue for the quarter came in at $58 million versus the consensus estimate of $43.37 million.
Immunocore Holdings plc (IMCR) reported Q4 EPS of ($0.63), $0.65 worse than the analyst estimate of $0.02. Revenue for the quarter came in at $58 million versus the consensus estimate of $43.37 million.